
Elli Peselev
Examiner (ID: 6644)
| Most Active Art Unit | 1623 |
| Art Unit(s) | 1803, 1673, 1211, 2899, 1623, 1621, 1203, 1802 |
| Total Applications | 2819 |
| Issued Applications | 1827 |
| Pending Applications | 143 |
| Abandoned Applications | 853 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 10142232
[patent_doc_number] => 09175031
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-11-03
[patent_title] => 'Ketolide compounds'
[patent_app_type] => utility
[patent_app_number] => 13/991762
[patent_app_country] => US
[patent_app_date] => 2011-02-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24481
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 5
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13991762
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/991762 | Ketolide compounds | Feb 2, 2011 | Issued |
Array
(
[id] => 6212414
[patent_doc_number] => 20110135714
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-06-09
[patent_title] => 'COMPOSITIONS FOR EXTERNAL APPLICATION, CONTAINING ADENOSYL COBALAMIN FOR IMPROVEMENT OF SKIN DISEASES'
[patent_app_type] => utility
[patent_app_number] => 13/016682
[patent_app_country] => US
[patent_app_date] => 2011-01-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7316
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0135/20110135714.pdf
[firstpage_image] =>[orig_patent_app_number] => 13016682
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/016682 | COMPOSITIONS FOR EXTERNAL APPLICATION, CONTAINING ADENOSYL COBALAMIN FOR IMPROVEMENT OF SKIN DISEASES | Jan 27, 2011 | Abandoned |
Array
(
[id] => 9977701
[patent_doc_number] => 09024012
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-05-05
[patent_title] => 'Methods to treat mixtures of glycosides to obtain one or more of these glycosides in more pure form'
[patent_app_type] => utility
[patent_app_number] => 13/575751
[patent_app_country] => US
[patent_app_date] => 2011-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 12057
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 166
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13575751
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/575751 | Methods to treat mixtures of glycosides to obtain one or more of these glycosides in more pure form | Jan 26, 2011 | Issued |
Array
(
[id] => 10870412
[patent_doc_number] => 08895610
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2014-11-25
[patent_title] => 'Platinum (IV) compounds targeting zinc finger domains'
[patent_app_type] => utility
[patent_app_number] => 13/011613
[patent_app_country] => US
[patent_app_date] => 2011-01-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 16
[patent_no_of_words] => 27946
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13011613
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/011613 | Platinum (IV) compounds targeting zinc finger domains | Jan 20, 2011 | Issued |
Array
(
[id] => 8854163
[patent_doc_number] => 20130143837
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-06-06
[patent_title] => 'INHIBITION OF TNF-ALPHA INDUCED ACTIVATION OF NFKB BY PENTOSAN POLYSULFATE'
[patent_app_type] => utility
[patent_app_number] => 13/522441
[patent_app_country] => US
[patent_app_date] => 2011-01-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 24117
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13522441
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/522441 | Inhibition of TNF-α induced activation of NFKB by pentosan polysulfate | Jan 13, 2011 | Issued |
Array
(
[id] => 9299822
[patent_doc_number] => 08648050
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-02-11
[patent_title] => 'Methods and formulations for reducing amphotericin B treatment side effects'
[patent_app_type] => utility
[patent_app_number] => 12/985256
[patent_app_country] => US
[patent_app_date] => 2011-01-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 19580
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12985256
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/985256 | Methods and formulations for reducing amphotericin B treatment side effects | Jan 4, 2011 | Issued |
Array
(
[id] => 5984821
[patent_doc_number] => 20110097412
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-04-28
[patent_title] => 'METHODS OF TREATMENT OF ENDOBRONCHIAL INFECTIONS'
[patent_app_type] => utility
[patent_app_number] => 12/984110
[patent_app_country] => US
[patent_app_date] => 2011-01-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 21274
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0097/20110097412.pdf
[firstpage_image] =>[orig_patent_app_number] => 12984110
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/984110 | METHODS OF TREATMENT OF ENDOBRONCHIAL INFECTIONS | Jan 3, 2011 | Abandoned |
Array
(
[id] => 8780579
[patent_doc_number] => 20130102554
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-04-25
[patent_title] => 'COMPOSITION FOR TREATMENT OF OBESITY USING WHEAT BRAN EXTRACT OR ACTIVE INGREDIENT ISOLATED THEREFROM'
[patent_app_type] => utility
[patent_app_number] => 13/520161
[patent_app_country] => US
[patent_app_date] => 2010-12-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 6014
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13520161
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/520161 | COMPOSITION FOR TREATMENT OF OBESITY USING WHEAT BRAN EXTRACT OR ACTIVE INGREDIENT ISOLATED THEREFROM | Dec 29, 2010 | Abandoned |
Array
(
[id] => 8618178
[patent_doc_number] => 20130023489
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-01-24
[patent_title] => 'COMPOSITIONS AND METHODS FOR PREVENTING AND TREATING DISEASES AND ENVIRONMENTALLY INDUCED HEALTH DISORDERS'
[patent_app_type] => utility
[patent_app_number] => 13/519049
[patent_app_country] => US
[patent_app_date] => 2010-12-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 27337
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13519049
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/519049 | COMPOSITIONS AND METHODS FOR PREVENTING AND TREATING DISEASES AND ENVIRONMENTALLY INDUCED HEALTH DISORDERS | Dec 23, 2010 | Abandoned |
Array
(
[id] => 7791775
[patent_doc_number] => 20120053331
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-03-01
[patent_title] => 'GLYCOL CHITOSAN DERIVATIVE, PREPARATION METHOD THEREOF AND DRUG DELIVERY SYSTEM COMPRISING THE SAME'
[patent_app_type] => utility
[patent_app_number] => 12/974841
[patent_app_country] => US
[patent_app_date] => 2010-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 4063
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0053/20120053331.pdf
[firstpage_image] =>[orig_patent_app_number] => 12974841
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/974841 | Glycol chitosan derivative, preparation method thereof and drug delivery system comprising the same | Dec 20, 2010 | Issued |
Array
(
[id] => 10533774
[patent_doc_number] => 09259389
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-02-16
[patent_title] => 'Pharmaceutical oral dosage form containing a synthetic oligosaccharide'
[patent_app_type] => utility
[patent_app_number] => 13/515965
[patent_app_country] => US
[patent_app_date] => 2010-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15213
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 194
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13515965
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/515965 | Pharmaceutical oral dosage form containing a synthetic oligosaccharide | Dec 16, 2010 | Issued |
Array
(
[id] => 8697796
[patent_doc_number] => 20130059805
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-03-07
[patent_title] => 'COMPOSITION COMPRISING AN AMORPHOUS NON-CRYSTALLINE GLASS FORM OF AZITHROMYCIN'
[patent_app_type] => utility
[patent_app_number] => 13/516942
[patent_app_country] => US
[patent_app_date] => 2010-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 4161
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13516942
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/516942 | COMPOSITION COMPRISING AN AMORPHOUS NON-CRYSTALLINE GLASS FORM OF AZITHROMYCIN | Dec 14, 2010 | Abandoned |
Array
(
[id] => 8671397
[patent_doc_number] => 20130045936
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-02-21
[patent_title] => 'COMPOSITION COMPRISING AN AMORPHOUS NON-CRYSTALLINE GLASS FORM OF ROXITHROMYCIN'
[patent_app_type] => utility
[patent_app_number] => 13/516864
[patent_app_country] => US
[patent_app_date] => 2010-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 2987
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13516864
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/516864 | Composition comprising an amorphous non-crystalline glass form of roxithromycin | Dec 14, 2010 | Issued |
Array
(
[id] => 6213913
[patent_doc_number] => 20110136752
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-06-09
[patent_title] => 'NOVEL ANTIBIOTICS'
[patent_app_type] => utility
[patent_app_number] => 12/960973
[patent_app_country] => US
[patent_app_date] => 2010-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 13508
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0136/20110136752.pdf
[firstpage_image] =>[orig_patent_app_number] => 12960973
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/960973 | NOVEL ANTIBIOTICS | Dec 5, 2010 | Abandoned |
Array
(
[id] => 6125510
[patent_doc_number] => 20110086053
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-04-14
[patent_title] => 'Glycolipids And Analogues Thereof As Antigens For NKT Cells'
[patent_app_type] => utility
[patent_app_number] => 12/958996
[patent_app_country] => US
[patent_app_date] => 2010-12-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 39
[patent_figures_cnt] => 39
[patent_no_of_words] => 29922
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0086/20110086053.pdf
[firstpage_image] =>[orig_patent_app_number] => 12958996
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/958996 | Glycolipids and analogues thereof as antigens for NKT cells | Dec 1, 2010 | Issued |
Array
(
[id] => 5986774
[patent_doc_number] => 20110098260
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-04-28
[patent_title] => 'Steroid Compounds and Formulations'
[patent_app_type] => utility
[patent_app_number] => 12/957661
[patent_app_country] => US
[patent_app_date] => 2010-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 64620
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0098/20110098260.pdf
[firstpage_image] =>[orig_patent_app_number] => 12957661
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/957661 | Steroid compounds and formulations | Nov 30, 2010 | Issued |
Array
(
[id] => 6039473
[patent_doc_number] => 20110092522
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-04-21
[patent_title] => 'Wound and Skin Care Procuts'
[patent_app_type] => utility
[patent_app_number] => 12/952633
[patent_app_country] => US
[patent_app_date] => 2010-11-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 17088
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0092/20110092522.pdf
[firstpage_image] =>[orig_patent_app_number] => 12952633
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/952633 | Wound and skin care compositions | Nov 22, 2010 | Issued |
Array
(
[id] => 8829956
[patent_doc_number] => 20130131001
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-05-23
[patent_title] => 'Epirubicin Derivatives'
[patent_app_type] => utility
[patent_app_number] => 13/508035
[patent_app_country] => US
[patent_app_date] => 2010-11-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11811
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13508035
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/508035 | Epirubicin derivatives | Nov 2, 2010 | Issued |
Array
(
[id] => 8187177
[patent_doc_number] => 20120116066
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-05-10
[patent_title] => 'EFFICIENT AND SCALABLE PROCESS FOR THE MANUFACTURE OF FONDAPARINUX SODIUM'
[patent_app_type] => utility
[patent_app_number] => 12/915864
[patent_app_country] => US
[patent_app_date] => 2010-10-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 17969
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0116/20120116066.pdf
[firstpage_image] =>[orig_patent_app_number] => 12915864
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/915864 | Efficient and scalable process for the manufacture of Fondaparinux sodium | Oct 28, 2010 | Issued |
Array
(
[id] => 8359593
[patent_doc_number] => 20120214753
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-08-23
[patent_title] => 'PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION'
[patent_app_type] => utility
[patent_app_number] => 13/502453
[patent_app_country] => US
[patent_app_date] => 2010-10-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 7587
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13502453
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/502453 | PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION | Oct 21, 2010 | Abandoned |